• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Wedbush initiated coverage on Albireo Pharma with a new price target

    3/28/22 8:34:41 AM ET
    $ALBO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALBO alert in real time by email
    Wedbush initiated coverage of Albireo Pharma with a rating of Outperform and set a new price target of $75.00
    Get the next $ALBO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALBO

    DatePrice TargetRatingAnalyst
    1/9/2023$53.00 → $42.00Outperform → Neutral
    Wedbush
    9/8/2022$55.00Buy
    Guggenheim
    3/28/2022$75.00Outperform
    Wedbush
    11/5/2021$79.00 → $80.00Buy
    HC Wainwright & Co.
    9/16/2021$82.00 → $84.00Outperform
    Wedbush
    7/21/2021$73.00 → $82.00Outperform
    Wedbush
    More analyst ratings